Headquartered in Kenilworth, New Jersey, Merck is a global pharmaceuticals company offering products that include biologic therapies, vaccines, prescription medications, and animal-health goods. As an employer, Merck offers a positive, high-performance work environment and seeks candidates at all stages of their careers. The company regularly hires for flexible jobs in the form of part-time, freelance, and remote positions in the areas of research, marketing, computer & IT, science, clinical research, and sales.

Founded in 1891, Merck has been responsible for many medical innovations, including being the first to synthesize Vitamin B1 in 1936, greatly reducing vitamin-B1 deficiency, also known as Beriberi. Today, Merck's research and development team is dedicated to addressing the world’s greatest health challenges. The company is currently conducting research into therapies for cancer, hepatitis C, diabetes, Alzheimer's, and infectious diseases, as well as developing new vaccines.

Serving customers in over 140 countries, Merck aims to deliver innovative health solutions and lifesaving therapies to people around the world. The company's primary product categories include infectious diseases, oncology, respiratory health, women’s health, and sun care. Merck is also involved with programs aimed at increasing access to healthcare by donating and delivering its products to vulnerable populations across the globe.

Headquartered in Kenilworth, New Jersey, Merck is a global pharmaceuticals company offering products that include biologic therapies, vaccines, prescription medications, and animal-health goods. As an employer, Merck offers a positive, high-performance work environment and seeks candidates at all stages of their careers. The company regularly hires for flexible jobs in the form of part-time, freelance, and remote positions in the areas of research, marketing, computer & IT, science, clinical research, and sales.

Founded in 1891, Merck has been responsible for many medical innovations, including being the first to synthesize Vitamin B1 in 1936, greatly reducing vitamin-B1 deficiency, also known as Beriberi. Today, Merck's research and development team is dedicated to addressing the world’s greatest health challenges. The company is currently conducting research into therapies for cancer, hepatitis C, diabetes, Alzheimer's, and infectious diseases, as well as developing new vaccines.

Serving customers in over 140 countries, Merck aims to deliver innovative health solutions and lifesaving therapies to people around the world. The company's primary product categories include infectious diseases, oncology, respiratory health, women’s health, and sun care. Merck is also involved with programs aimed at increasing access to healthcare by donating and delivering its products to vulnerable populations across the globe.